Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11


Sphingosine Kinase 1 Signaling Promotes Metastasis of Triple-Negative Breast Cancer.

Acharya S, Yao J, Li P, Zhang C, Lowery FJ, Zhang Q, Guo H, Qu J, Yang F, Wistuba II, Piwnica-Worms H, Sahin AA, Yu D.

Cancer Res. 2019 Aug 15;79(16):4211-4226. doi: 10.1158/0008-5472.CAN-18-3803. Epub 2019 Jun 25.


Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers.

Parkhurst MR, Robbins PF, Tran E, Prickett TD, Gartner JJ, Jia L, Ivey G, Li YF, El-Gamil M, Lalani A, Crystal JS, Sachs A, Groh E, Ray S, Ngo LT, Kivitz S, Pasetto A, Yossef R, Lowery FJ, Goff SL, Lo W, Cafri G, Deniger DC, Malekzadeh P, Ahmadzadeh M, Wunderlich JR, Somerville RPT, Rosenberg SA.

Cancer Discov. 2019 Aug;9(8):1022-1035. doi: 10.1158/2159-8290.CD-18-1494. Epub 2019 Jun 4.


Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis.

Zhang C, Lowery FJ, Yu D.

J Vis Exp. 2017 Feb 8;(120). doi: 10.3791/55085.


Brain metastasis: Unique challenges and open opportunities.

Lowery FJ, Yu D.

Biochim Biophys Acta Rev Cancer. 2017 Jan;1867(1):49-57. doi: 10.1016/j.bbcan.2016.12.001. Epub 2016 Dec 6. Review.


Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth.

Zhang L, Zhang S, Yao J, Lowery FJ, Zhang Q, Huang WC, Li P, Li M, Wang X, Zhang C, Wang H, Ellis K, Cheerathodi M, McCarty JH, Palmieri D, Saunus J, Lakhani S, Huang S, Sahin AA, Aldape KD, Steeg PS, Yu D.

Nature. 2015 Nov 5;527(7576):100-104. doi: 10.1038/nature15376. Epub 2015 Oct 19.


14-3-3ζ turns TGF-β's function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2.

Xu J, Acharya S, Sahin O, Zhang Q, Saito Y, Yao J, Wang H, Li P, Zhang L, Lowery FJ, Kuo WL, Xiao Y, Ensor J, Sahin AA, Zhang XH, Hung MC, Zhang JD, Yu D.

Cancer Cell. 2015 Feb 9;27(2):177-92. doi: 10.1016/j.ccell.2014.11.025.


Inhibition of type I insulin-like growth factor receptor signaling attenuates the development of breast cancer brain metastasis.

Saldana SM, Lee HH, Lowery FJ, Khotskaya YB, Xia W, Zhang C, Chang SS, Chou CK, Steeg PS, Yu D, Hung MC.

PLoS One. 2013 Sep 5;8(9):e73406. doi: 10.1371/journal.pone.0073406. eCollection 2013.


SRC family kinases as novel therapeutic targets to treat breast cancer brain metastases.

Zhang S, Huang WC, Zhang L, Zhang C, Lowery FJ, Ding Z, Guo H, Wang H, Huang S, Sahin AA, Aldape KD, Steeg PS, Yu D.

Cancer Res. 2013 Sep 15;73(18):5764-74. doi: 10.1158/0008-5472.CAN-12-1803. Epub 2013 Aug 1.


Growth factor signaling in metastasis: current understanding and future opportunities.

Lowery FJ, Yu D.

Cancer Metastasis Rev. 2012 Dec;31(3-4):479-91. doi: 10.1007/s10555-012-9380-x. Review.


High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology.

Anagnostou VK, Lowery FJ, Zolota V, Tzelepi V, Gopinath A, Liceaga C, Panagopoulos N, Frangia K, Tanoue L, Boffa D, Gettinger S, Detterbeck F, Homer RJ, Dougenis D, Rimm DL, Syrigos KN.

BMC Cancer. 2010 May 9;10:186. doi: 10.1186/1471-2407-10-186.


Quantitative evaluation of protein expression as a function of tissue microarray core diameter: is a large (1.5 mm) core better than a small (0.6 mm) core?

Anagnostou VK, Lowery FJ, Syrigos KN, Cagle PT, Rimm DL.

Arch Pathol Lab Med. 2010 Apr;134(4):613-9. doi: 10.1043/1543-2165-134.4.613.


Supplemental Content

Loading ...
Support Center